Key result
Hybrid clinical decision support using machine learning strongly predicts pharmacist interventions for anticoagulant prescriptions.
Why the study?
Anticoagulant prescribing errors remain common despite the use of clinical decision support systems, which are limited by alert fatigue and interpretability.
Does a hybrid rule-based and machine learning-based clinical decision support system accurately predict the need for pharmacist intervention in anticoagulant prescriptions?
Observational (n=75,200)
Yes
Does a hybrid rule-based and machine learning-based clinical decision support system accurately predict the need for pharmacist intervention in anticoagulant prescriptions?
Effect estimate: AUROC 0.871-0.963
A hybrid clinical decision support system combining rule-based logic and machine learning accurately identifies anticoagulant prescriptions requiring pharmacist intervention, potentially reducing alert fatigue.
Hybrid CDSS may curb anticoagulant errors and alert fatigue; leaves open prospective outcome impact before practice change.
Background Anticoagulants are high-alert medications with substantial risk of serious bleeding, yet dosing and prescribing errors remain common. Although clinical decision support systems (CDSSs) can mitigate these errors, their impact is constrained by alert fatigue and limited interpretability. Objective We developed and validated a hybrid CDSS that integrates rule-based logic with machine learning to improve the safe use of anticoagulants. Methods This multicenter study used electronic health record data on anticoagulant prescriptions from 3 tertiary hospitals (1 for system development and internal validation and 2 for external validation). The hybrid CDSS combined a knowledge-based rule engine with a machine learning model trained to predict whether an anticoagulant prescription would require pharmacist intervention. The system was iteratively refined through pilot testing, internal validation, and external validation. Results A total of 75,200 anticoagulant prescriptions were used for model development. The final hybrid CDSS comprised 44 patient-specific rules and 1129 drug-drug interaction rules, combined with a CatBoost classifier (version 1.2.5; Yandex) for alert prioritization. During internal validation, 88 (18.9%) alerts were generated; all were technically correct; 88.6% (n=78) were deemed clinically relevant; 86.4% (n=76) were considered clinically useful; and 13.6% (n=12) required pharmacist intervention. In external validation across 2 hospitals, alert rates ranged from 22.6% (7/31) to 32.1% (310/966), with 18.8% (22/117) to 57.1% (4/7) of alerts requiring pharmacist intervention. The hybrid CDSS showed strong discrimination (area under the receiver operating characteristic curve 0.871‐0.963). No false negatives were identified, but the estimates should be interpreted cautiously given the short validation periods and limited number of intervention-requiring prescriptions. Conclusions A hybrid CDSS integrating rule-based logic with machine learning demonstrated high technical accuracy and clinical relevance across multiple institutions, suggesting its potential as a practical tool for supporting pharmacist-led anticoagulant prescription review.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2026) conducted an observational in Anticoagulant prescriptions (n=75,200). Hybrid clinical decision support system (CDSS) was evaluated on Discrimination for predicting pharmacist intervention (AUROC 0.871-0.963). A hybrid clinical decision support system integrating rule-based logic with machine learning demonstrated strong discrimination (AUROC 0.871-0.963) for predicting pharmacist intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: